Results
1 -
4 of
4Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor ??/?? agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome, Cardiovascular Diabetology Imiglitazar development on hold because of safety concerns, Inpharma Weekly